Chargement en cours...
Is Newer Safer? Adverse Events Associated with First-Line Therapies for ANCA-Associated Vasculitis and Lupus Nephritis
Clinical outcomes in ANCA-associated vasculitis (AAV) and lupus nephritis have improved greatly with treatment regimens containing high-dose glucocorticoids and cyclophosphamide. However, with the use of these medications come significant adverse events, most notably infections, cytopenias, malignan...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society of Nephrology
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4152805/ https://ncbi.nlm.nih.gov/pubmed/24832093 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.01600214 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|